Author Correction: In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial

Nature Medicine has issued an author correction to a paper on in vivo base editing gene therapy for heterozygous familial hypercholesterolemia, which reported a phase 1 trial. No further details of the correction are provided.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.